Two-year disease-free survival from evaluable Phase 2 patients expected by the end of Q1 2028.Strasbourg, France, April 13, 2026, 8:00 a.m. CET – ...
Three waterways in Berks County are targeted by the Pennsylvania Department of Environmental Protection for spraying to ...
Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.
U.S. FDA Grants RMAT Designation to GS-100, Grace Science’s Gene Therapy to Treat NGLY1 Deficiency
Grace Science, LLC, a biotechnology company founded to develop novel therapies based on the function of NGLY1, announced ...
Oligo Security moves beyond CVE prioritization with real-time application-layer exploit blocking - SiliconANGLE ...
The success of the Artemis 2 Space Mission is now propelling the men and women of the Elma-based Moog Corporation to work and ...
Assurant leans into capital-light, fee-based growth and AI-driven efficiency, with Connected Living and Housing fueling ...
As warming temperatures spread dengue to new regions, Stanford researchers are using AI-powered drones to hunt down hidden ...
Virica Biotech (“Virica”), a cell enhancer company specializing in Viral Sensitizers (VSE™) for viral vector manufacturing, today announced it is receiving advisory services and funding from the ...
Malaria remains a major global health burden, with hundreds of millions of cases reported annually, primarily in sub-Saharan Africa and parts of Asia and ...
Stolen credentials turn authentication systems into the attack surface. Token shows how wearable biometric authentication ...
Kansas companies played a critical role in the success of NASA's Artemis II mission, supplying parts, materials and technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results